Likewise, Stewart et al.[68] found that CD133 expression changed in ovarian cancer cells during passaging, suggesting that CD133 only marked ovarian CSCs under defined conditions and the hierarchical organization in ovarian cancers was not stable. The gene discussed is PROM1; the disease is ovarian carcinoma.